GUD

Knight Therapeutics Inc

CA$5.78+CA$0.03  (0.52%)
P/E
57.8
EPS
0.1
Market cap
CA$575.85M
Start your journey to financial independence ✨
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently asked questions

What sector does Knight Therapeutics Inc (GUD) operate in?

Knight Therapeutics Inc belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Knight Therapeutics Inc (GUD) current stock price?

As of the latest data, Knight Therapeutics Inc stock price is CA$5.78, with a previous close of CA$5.75. Knight Therapeutics Inc gained CA$0.03 in the last trading session, representing a 0.52% increase.

What is Knight Therapeutics Inc (GUD) current market capitalization?

Knight Therapeutics Inc market cap is approximately 575.85 million.

What is Knight Therapeutics Inc (GUD) Earnings Per Share (EPS)?

The trailing EPS is CA$0.10, and the forward EPS is CA$0.06.

What is Knight Therapeutics Inc (GUD) Price-to-Earnings (P/E) ratio?

Knight Therapeutics Inc current P/E ratio is 57.8, with a forward P/E of 96.33.

Does Knight Therapeutics Inc (GUD) pay dividends?

No. Knight Therapeutics Inc does not pay a dividend.

What is Knight Therapeutics Inc (GUD) beta (volatility) score?

Knight Therapeutics Inc has a beta of 0.169, indicating lower volatility than the overall market.